Fenwick represented SymphonyRM, a healthcare software company helping health systems transform how they acquire, engage and retain patients, in its $25 million Series B financing. The round was led by new investment partner TT Capital Partners with continued investment from Adams Street Partners.
The capital injection will further fuel SymphonyRM’s sales and marketing efforts to support the accelerated demand for actionable intelligence that helps provider and payer organizations maximize patient outcomes and revenue growth. The company also plans to increase its reach and footprint in the payer segment by leveraging data science and sophisticated AI, to create next best actions that improve member experiences. More information can be obtained from SymphonyRM’s announcement.
The Fenwick transaction team included corporate partners Michael Brown and Patrick Grilli and associate Harrison Dilday.